...
首页> 外文期刊>Phytotherapy research: PTR >Anti‐Obesity Activity of Saringosterol Isolated from Sargassum muticum Sargassum muticumSargassum muticum (Yendo) Fensholt Extract in 3T3‐L1 Cells
【24h】

Anti‐Obesity Activity of Saringosterol Isolated from Sargassum muticum Sargassum muticumSargassum muticum (Yendo) Fensholt Extract in 3T3‐L1 Cells

机译:Saringosterol的抗肥胖活动从 sargassum muticum sargassum muticum(yendo)fensholt提取物在3t3-l1细胞中

获取原文
获取原文并翻译 | 示例

摘要

> Saringosterol, a steroid isolated from Sargassum muticum , a brown edible alga widely distributed on the seashores of southern and eastern Korea, has been shown to exhibit anti‐obesity effect. In this study, we investigated the anti‐obesity activity of saringosterol through various experiments. The inhibitory effect of saringosterol on adipogenesis was evaluated via Oil Red O staining in 3T3‐L1 preadipocytes. After confirming that saringosterol is not cytotoxic to these cells by using the 3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyltetrazolium bromide assay, the effect of saringosterol on the expression of various adipogenesis‐related genes was analyzed via quantitative real‐time polymerase chain reaction and western blotting. We demonstrated that saringosterol dose dependently inhibited adipocyte differentiation and expression of adipogenic marker genes such as adipocyte fatty acid‐binding protein, adiponectin, resistin, and fatty acid synthase in 3T3‐L1 cells. In addition, saringosterol significantly inhibited the mRNA and protein expression of peroxisome proliferator‐activated receptor γ and CCAAT enhancer‐binding protein α in 3T3‐L1 cells. Collectively, these findings indicate that saringosterol isolated from S. muticum exhibits anti‐obesity effect by inhibiting the expression of adipogenic transcription factors and marker genes and that it may be developed as a drug to suppress adipogenesis. Copyright ? 2017 John Wiley & Sons, Ltd.
机译: > saringosterol,从 sargassum muticum 中分离的类固醇棕色可食用藻类广泛分布在南部和东部朝鲜海岸,已被证明表现出抗肥胖效应。在这项研究中,我们通过各种实验研究了Saringosterol的抗肥胖活性。 Saringosterols在3T3-L1前脂肪细胞中的油红溶液评估了Saringosterols对脂肪发生的抑制作用。通过使用3- [4,5-二甲基噻唑-2-基] -2,5-二苯基四唑粒溴化物测定法确认Saringosterol对这些细胞没有细胞毒性,分析了Saringosterolol对各种脂肪发生相关基因表达的影响通过定量实时聚合酶链反应和蛋白质印迹。我们证明Saringosterol依赖性抑制脂肪细胞分化和表达脂肪细胞脂肪酸基因,例如脂肪细胞脂肪酸结合蛋白,脂联素,抵抗蛋白和脂肪酸合成酶,如3T3-L1细胞。此外,Saringosterol在3T3-L1细胞中显着抑制过氧化物体增殖物激活受体γ和CCAAT增强剂结合蛋白α的mRNA和蛋白表达。总的来说,这些发现表明Saringosterol从 s中分离。 Muticum 通过抑制脂肪转录因子和标记基因的表达来表现出抗肥胖效果,并且它可以作为抑制脂肪发生的药物开发。版权? 2017年John Wiley& SONS,LTD。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号